San Francisco, California, June 26, 2018 – The global friction modifiers market is anticipated to gain impetus due to the expansion of the transportation industry. Broadening scope of the market and rise in use of lubricants could be other factors augmenting the demand for friction modifiers. A report by TMR Research provides a detailed account of the market and sheds light on factors that could shape market growth in the near future. It bears the title “Friction Modifiers Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025.” There could be strong growth prospects birthed in the market as a result of the implementation of stringent government regulations.
Get Sample Copy of this Report @
Inorganic friction modifiers are foreseen to gather more pace in the global market. Their economic pricing could be a leading factor helping it gain traction in the market. They are expected to collect strong demand in the market because of their outstanding performance and exceptional friction reduction. Rise of the automotive industry and increasing vehicle parc are predicted to set the tone for significant growth in the global friction modifiers market. Growth of the market could also be pushed by swelling demand for fuel-efficient lubricants. However, demand for friction modifiers is foretold to decrease as electric vehicles win high preference and alternative fuels increase their application.
Nonetheless, there could be a wealth of opportunities available in the global friction modifiers market due to increasing research and development investment and advancement of friction modifier additive technologies. On the regional front, the market is envisioned to witness the dominance of Asia Pacific in the coming years. This could be on account of promising market situations in prime economies of the region. Some of these countries are also reputed as automotive hubs of Asia Pacific.
Read Comprehensive Overview of Report @
The global friction modifiers market includes leading companies such as Lubrizol, Afton, and Infineum.